These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 38375688
1. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway. Bao Y, Xu S, Zhou J, Zhao C, Dai S, Zhang Y, Rao M. J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688 [Abstract] [Full Text] [Related]
2. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J, Nan K, Yao Y, Tian T. J Exp Clin Cancer Res; 2018 Mar 12; 37(1):52. PubMed ID: 29530052 [Abstract] [Full Text] [Related]
9. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X. Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740 [Abstract] [Full Text] [Related]
10. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma. Yang B, Feng X, Liu H, Tong R, Wu J, Li C, Yu H, Chen Y, Cheng Q, Chen J, Cai X, Wu W, Lu Y, Hu J, Liang K, Lv Z, Wu J, Zheng S. Oncogene; 2020 Oct 06; 39(42):6529-6543. PubMed ID: 32917956 [Abstract] [Full Text] [Related]
11. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Li W, Dong X, He C, Tan G, Li Z, Zhai B, Feng J, Jiang X, Liu C, Jiang H, Sun X. J Exp Clin Cancer Res; 2019 May 03; 38(1):183. PubMed ID: 31053148 [Abstract] [Full Text] [Related]
12. miR-218 modulate hepatocellular carcinoma cell proliferation through PTEN/AKT/PI3K pathway and HoxA10. Xiao ZD, Jiao CY, Huang HT, He LJ, Zhao JJ, Lu ZY, Liu LX. Int J Clin Exp Pathol; 2014 May 03; 7(7):4039-44. PubMed ID: 25120782 [Abstract] [Full Text] [Related]
13. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1. Guo XL, Wang HB, Yong JK, Zhong J, Li QH. Eur Rev Med Pharmacol Sci; 2018 Oct 03; 22(20):6667-6677. PubMed ID: 30402839 [Abstract] [Full Text] [Related]
14. Circ_0004018 suppresses cell proliferation and migration in hepatocellular carcinoma via miR-1197/PTEN/PI3K/AKT signaling pathway. Wang H, Zhang Q, Cui W, Li W, Zhang J. Cell Cycle; 2021 Oct 03; 20(20):2125-2136. PubMed ID: 34570663 [Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. Zhou Y, Ren H, Dai B, Li J, Shang L, Huang J, Shi X. J Exp Clin Cancer Res; 2018 Dec 27; 37(1):324. PubMed ID: 30591064 [Abstract] [Full Text] [Related]
17. KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma. Liu J, Nie C. Anticancer Drugs; 2022 Oct 01; 33(9):840-849. PubMed ID: 35946516 [Abstract] [Full Text] [Related]
18. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A. Ohta K, Hoshino H, Wang J, Ono S, Iida Y, Hata K, Huang SK, Colquhoun S, Hoon DS. Oncotarget; 2015 Feb 20; 6(5):3211-24. PubMed ID: 25633810 [Abstract] [Full Text] [Related]
19. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway. Kannan M, Jayamohan S, Moorthy RK, Chabattula SC, Ganeshan M, Arockiam AJV. Int J Mol Sci; 2019 Nov 06; 20(22):. PubMed ID: 31698701 [Abstract] [Full Text] [Related]
20. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF, Dai H, Ou Q, Zuo GQ, Liu CA. Tumour Biol; 2016 May 06; 37(5):5885-95. PubMed ID: 26589417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]